BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9721869)

  • 1. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
    Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
    J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of protein phosphatases PP1, PP2A, PP4 and Cdc14 in the DNA damage response.
    Ramos F; Villoria MT; Alonso-Rodríguez E; Clemente-Blanco A
    Cell Stress; 2019 Feb; 3(3):70-85. PubMed ID: 31225502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Strategies Employed for the Construction of Fostriecin and Related Natural Products.
    Trost BM; Knopf JD; Brindle CS
    Chem Rev; 2016 Dec; 116(24):15035-15088. PubMed ID: 28027648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.
    Theobald B; Bonness K; Musiyenko A; Andrews JF; Urban G; Huang X; Dean NM; Honkanen RE
    Mol Cancer Res; 2013 Aug; 11(8):845-55. PubMed ID: 23671329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin.
    Huertas D; Soler M; Moreto J; Villanueva A; Martinez A; Vidal A; Charlton M; Moffat D; Patel S; McDermott J; Owen J; Brotherton D; Krige D; Cuthill S; Esteller M
    Oncogene; 2012 Mar; 31(11):1408-18. PubMed ID: 21804608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphatase 1γ is responsible for dephosphorylation of histone H3 at Thr 11 after DNA damage.
    Shimada M; Haruta M; Niida H; Sawamoto K; Nakanishi M
    EMBO Rep; 2010 Nov; 11(11):883-9. PubMed ID: 20948546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability.
    Houston SI; McManus KJ; Adams MM; Sims JK; Carpenter PB; Hendzel MJ; Rice JC
    J Biol Chem; 2008 Jul; 283(28):19478-88. PubMed ID: 18480059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.
    Lawhorn BG; Boga SB; Wolkenberg SE; Colby DA; Gauss CM; Swingle MR; Amable L; Honkanen RE; Boger DL
    J Am Chem Soc; 2006 Dec; 128(51):16720-32. PubMed ID: 17177422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.
    Arachchige Don AS; Dallapiazza RF; Bennin DA; Brake T; Cowan CE; Horne MC
    Exp Cell Res; 2006 Dec; 312(20):4181-204. PubMed ID: 17123511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4.
    Zhang X; Ozawa Y; Lee H; Wen YD; Tan TH; Wadzinski BE; Seto E
    Genes Dev; 2005 Apr; 19(7):827-39. PubMed ID: 15805470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of serine/threonine protein phosphatases in exocytosis.
    Sim AT; Baldwin ML; Rostas JA; Holst J; Ludowyke RI
    Biochem J; 2003 Aug; 373(Pt 3):641-59. PubMed ID: 12749763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylation of cyclin-dependent kinases by type 2C protein phosphatases.
    Cheng A; Ross KE; Kaldis P; Solomon MJ
    Genes Dev; 1999 Nov; 13(22):2946-57. PubMed ID: 10580002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
    Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
    Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A.
    Roberge M; Tudan C; Hung SM; Harder KW; Jirik FR; Anderson H
    Cancer Res; 1994 Dec; 54(23):6115-21. PubMed ID: 7954457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
    Messner DJ; Romeo C; Boynton A; Rossie S
    J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Okadaic acid inhibits a protein phosphatase activity involved in formation of the mitotic spindle of GH4 rat pituitary cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1992 Jul; 152(1):190-8. PubMed ID: 1320037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of p53 in the response to mitotic spindle damage.
    Meek DW
    Pathol Biol (Paris); 2000 Apr; 48(3):246-54. PubMed ID: 10858957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fostriecin: a review of the preclinical data.
    de Jong RS; de Vries EG; Mulder NH
    Anticancer Drugs; 1997 Jun; 8(5):413-8. PubMed ID: 9215602
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.